What happens after we develop a COVID-19 vacc...

Aria Florant cofounded a nonprofit to help accelerate the reparations movement in the US … but less than a year in, her partnership with her own cofounder fell apart. Drawing on what brought the two of them back together — plus lessons from South Africa, Germany and Colombia — sh ...  Show more

What’s dirtier: your phone or your hands? Molecular biologist Lotti Tajouri says there’s a gaping hole in our hygiene routine. We scrub our hands clean, then reach right for the phone — a warm, humid and mobile home for bacteria and viruses. He explores the unnervingly vibrant mi ...  Show more

What does it feel like working on something that could save the world? CNN Chief Medical Correspondent Dr. Sanjay Gupta speaks with Hanneke Schuitemaker, PhD, the Global Head of Vaccine Discovery and Translational Medicine at Janssen Pharmaceutica. She reflects on her work leadin ...  Show more

We explore the science, scalability, and (of course) economics surrounding the global vaccine race. Guests include the chief medical officer of the first U.S. firm to go to Phase 3 trials with a vaccine candidate; a former F.D.A. commissioner who’s been warning of a pandemic f ...

With promising data coming out of multiple trials, the country is now looking at how to distribute a potential Covid-19 vaccine to the public. But who will get it first? CNN’s Chief Medical Correspondent Dr. Sanjay Gupta speaks with bioethicist Art Caplan about the many decisions ...  Show more